Goldline Pharmaceutical Ltd (544759)

Goldline Pharmaceutical Ltd recorded a single insider trading transaction during the past ninety days. On August 31, 2026, promoter and director Amol Laxmikant Mujumdar purchased 60,000 shares. This acquisition represents the sole market activity reported for the firm recently, occurring outside any scheduled earnings report cycle.
Ticker: 544759 Exchange: BSE


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Amol Laxmikant Mujumdar Promoter and Director Director Large shareholder
Transaction date
Purchase
Price
81.80
Quantity 83,633
Value ₹1,976,032
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-01 2026-08-31 B Purchase

Promoter and Director

Director Large shareholder
83,633
81.80
₹1,976,032
83,633 81.80 ₹1,976,032